Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) just unveiled an update.
EZZ Life Science Holdings Limited has appointed Glenn Cross as Chief Strategy Officer after his tenure as Chair of the Board. With over 40 years of experience in the life-science sector, Cross will continue to contribute to EZZ’s strategic initiatives, including product development and international expansion, particularly in the United States. The company is also seeking a new Non-Executive Chair to support its evolving global footprint.
The most recent analyst rating on (AU:EZZ) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited is a life science company focused on improving quality of life and human health. It invests in consumer health through e-commerce and distribution of high-quality products via omnichannel models across Australia, New Zealand, China, and globally. The company is expanding its market presence in the United States, a key growth market.
Average Trading Volume: 74,969
Technical Sentiment Signal: Sell
Current Market Cap: A$80.19M
Find detailed analytics on EZZ stock on TipRanks’ Stock Analysis page.